PureCycle Technologies

PureCycle Technologies Inc holds a global license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into virgin-like resin. The proprietary process removes color, odor and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.

PureCycle Technologies, Inc. - Common stock

PACT GROUP HLDGS UNSP/ADR by Pact Group Holdings Ltd

Pact Group Holdings

PCTEL

Keybanc analyst Leo Mariani maintains Whiting Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLL#NYSE">WLL</a>) with a Overweight and raises the price target from $55 to $58.

News

Price Target

Analyst Ratings

Keybanc Maintains Overweight on Whiting Petroleum, Raises Price Target to $58

Keybanc analyst Leo Mariani maintains Denbury (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEN#NYSE">DEN</a>) with a Overweight and raises the price target from $82 to $86.

Keybanc Maintains Overweight on Denbury, Raises Price Target to $86

Keybanc analyst Leo Mariani maintains Centennial Resource Dev (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDEV#NASDAQ">CDEV</a>) with a Overweight and raises the price target from $7 to $8.

CDEV

Keybanc Maintains Overweight on Centennial Resource Dev, Raises Price Target to $8

Keybanc maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Overweight and raises the price target from $98 to $102.

FANG

Keybanc Maintains Overweight on Diamondback Energy, Raises Price Target to $102

Some of the stocks that may grab investor focus today are:
<ul>
<li>Wall Street expects Accenture Plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acn#NYSE">ACN</a>) to report quarterly earnings at $2.24 per share on revenue of $12.77 billion before the opening bell. Accenture shares gained 0.5% to $287.10 in after-hours trading.</li>
<li>Steelcase Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scs#NASDAQ">SCS</a>) reported a narrower-than-expected loss for its first quarter, while sales exceeded views. The company also issued strong guidance for the second quarter. Steelcase shares climbed 5.7% to $15.37 in the after-hours trading session.</li>
<li>Analysts are expecting FedEx Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdx#NYSE">FDX</a>) to have earned $4.99 per share on revenue of $21.51 billion for the latest quarter. The company will release earnings after the markets close. FedEx shares rose 0.9% to $299.90 in after-hours trading.</li>
</ul>
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-online-brokerage/">Choosing the best broker is an important part of being a successful trader or investor</a>
<ul>
<li>KB Home (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kbh#NYSE">KBH</a>) reported upbeat earnings for its second quarter, while sales missed estimates. KB Home shares dropped 4.3% to $41.51 in the after-hours trading session.</li>
<li>Analysts expect Nike Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nke#NYSE">NKE</a>) to report quarterly earnings at $0.51 per share on revenue of $11.01 billion after the closing bell. Nike shares gained 0.2% to $133.35 in after-hours trading.</li>
</ul>

Earnings

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

5 Stocks To Watch For June 24, 2021

Keybanc analyst Sean Eastman upgrades EMCOR Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) from Sector Weight to Overweight and announces $146 price target.

Upgrades

Keybanc Upgrades EMCOR Gr to Overweight, Announces $146 Price Target

Apple Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) is looking to expand&nbsp;its revenue streams in China with the launch of its search advertising service this week, AppleInsider <a href="https://appleinsider.com/articles/21/06/23/apple-launches-limited-search-ads-in-mainland-china">reported</a> Wednesday.
What Happened: Apple has launched the advertising platform called Apple Search Ads in mainland China, enabling developers and advertisers to have App Store ads presented to users in the region, as per the report.
A <a href="https://www.appinchina.co/apple-search-ads-in-mainland-china">blog post</a> by AppInChina, an agency that helps international apps launch in China, noted that advertisers and businesses must gain state approval and industry-specific licenses to be able to advertise in mainland China.
Apple may reportedly submit the documents uploaded by the businesses to third-party databases and government entities for verification.
See Also: <a href="https://www.benzinga.com/news/21/06/21600296/apples-5g-smartphone-market-share-falls-after-initial-boom-as-samsung-vivo-register-high-growth">Apple&#39;s 5G Smartphone Market Share Falls After Initial Boom As Samsung, Vivo Register High Growth</a>
Why It Matters: Apple Search Ads is being launched in China five years after it was launched in the U.S. The launch is in compliance with Chinese regulations and comes after more than 2,500 games were <a href="https://www.benzinga.com/news/20/07/16623969/apple-china-app-store-sees-2-500-games-removed-in-one-week-sensortower">removed</a> from the App Store in China in July last year.
Apple is looking to diversify its revenue streams in China, which has traditionally been a strong market for the Cupertino-based company. The iPhone maker is now facing stiff competition from rival smartphone makers in China such as Huawei and Vivo.
The App Store was a significant driver of Apple&rsquo;s $16.9 billion in services revenue generated in the recent second quarter.
Price Action: Apple shares closed 0.2% lower in Wednesday&rsquo;s trading session at $133.70.
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/21/06/21678928/apple-ford-among-low-effort-buys-right-now-says-cramer">Apple, Ford Among &#39;Low-Effort&#39; Buys Right Now, Says Cramer</a>

Retail Sales

Tech

AAPL

Apple Looks To Widen China Revenue Streams With Launch Of Search Advertising Service

Alibaba Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baba#NYSE">BABA</a>)-backed Ant Group has sought to clarify that <a href="https://www.benzinga.com/money/what-is-a-non-fungible-token-nft/">non-fungible tokens</a> (NFTs) are not cryptocurrencies, according to a <a href="https://www.reuters.com/article/china-antgroup-nft/chinas-ant-highlights-distinction-between-nfts-and-cryptocurrencies-idUSL3N2O52YK">report</a> by Reuters.
What Happened: Ant&rsquo;s clarification came after 16,000 copies of NFTs representing two artworks were reportedly sold on its payment platform Alipay within hours on Wednesday.
According to the Reuters report, the Jack Ma-controlled fintech group&rsquo;s response was possibly related to China&rsquo;s <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21635080/chinas-cryptocurrency-mining-crackdown-intensifies-spreads-to-sichuan">intensified crackdown</a> on crypto mining operations in recent days.
Social media users in China had expressed concerns whether NFTs are linked to cryptocurrencies such as <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/">Bitcoin</a> (CRYPTO: BTC), which have the same underlying technology.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21686733/chinese-fintech-behemoth-alipay-now-sells-nfts">Chinese Fintech Behemoth Alipay Now Sells NFTs</a>
Why It Matters: NFTs, blockchain-based tokenization of collectible items or art pieces, allow users to own digital assets like retail estate, art, digital sneakers, and video moments. It is a digital asset that is unique and indivisible.
Some NFT artworks that have recorded sky-high valuations recently include Beeple&rsquo;s &lsquo;The First 5000 Days&rsquo; NFT based digital artwork, which was sold for <a href="https://www.benzinga.com/markets/cryptocurrency/21/03/20134939/beeple-nft-sold-for-a-record-69-million">$69 million</a> in an auction in March.
Doge, the classic meme behind the meme cryptocurrency Dogecoin (CRYPTO: DOGE), was recently sold for about <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21463795/doge-the-classic-meme-behind-dogecoin-cryptocurrency-to-be-auctioned-as-nft">$4 million</a> in an auction, making it the most expensive meme to be sold as NFT so far.
Price Action: Alibaba shares closed almost 1.7% higher in Wednesday&rsquo;s regular trading session at $214.86 and further rose almost 0.3% in the after-hours session to $215.40.&nbsp;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21582883/nft-marvel-marketplace-launches-on-binance">NFT Marvel Marketplace Launches On Binance</a>
For news coverage in French, Italian, or Spanish, check out <a href="https://fr.benzinga.com/">Benzinga France</a>, <a href="https://it.benzinga.com/">Benzinga Italia</a>, or <a href="https://es.benzinga.com/">Benzinga Espa&ntilde;a</a>.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

BABA

Alibaba's Ant Says NFTs Aren't Cryptocurrencies As 16,000 Art Copies Get Sold Out In A Blink

<ul>
<li>Data on durable goods orders for May will be released at 8:30 a.m. ET. Durable goods orders, which dropped 1.3% in April, are expected to increase 2.0% in May.</li>
<li>Gross Domestic Product report for the first quarter is scheduled for release at 8:30 a.m. ET. The first-quarter GDP is expected to increase 6.4%.</li>
<li>An advance report on U.S. international trade in goods will be released at 8:30 a.m. ET. The US goods deficit is likely to widen to $87.9 billion in May from $85.7 billion in April.</li>
<li>Data on initial jobless claims for the latest week will be released at 8:30 a.m. ET. Analysts expect jobless claims declining to 380,000 for the June 19 week from 412,000 in the prior week.</li>
<li>Data on wholesale inventories for May week will be released at 8:30 a.m. ET. Wholesale inventories are expected to rise 0.4% in May from a 0.3% increase in April.</li>
<li>The Energy Information Administration&rsquo;s weekly report on natural gas stocks in underground storage is scheduled for released at 10:30 a.m. ET.</li>
<li>Federal Reserve Bank of New York President John Williams is set to speak at 11:00 a.m. ET.</li>
<li>The Kansas City Fed manufacturing index for June will be released at 11:00 a.m. ET. Analysts expect the index rising to 29 in June from 26 in the previous month.</li>
<li>The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.</li>
<li>Dallas Fed President Robert Kaplan will speak at 1:00 p.m. ET.</li>
<li>St. Louis Fed President James Bullard is set to speak at 1:00 p.m. ET.</li>
<li>The Treasury will auction 7-year notes at 1:00 p.m. ET.</li>
</ul>
<a href="https://www.benzinga.com/calendar/economics/">Check out the full economic calendar here </a>

Economics

Economic Data Scheduled For Thursday

SpaceX founder Elon Musk said on Thursday he would look to give long-term Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) shareholders preference in the Starlink initial public offering as and when that happens.
What Happened: In a tweet response to a query seeking details on the Starlink IPO, Musk said that wouldn&#39;t happen until the unit&nbsp;delivers a &ldquo;reasonably predictable&rdquo; revenue, which is still a few years away, adding he would do his best to ensure long-term Tesla shareholders get preference.&nbsp;
Musk, who leads Tesla alongside SpaceX,&nbsp;said a public listing before the business attains steady revenue would be &ldquo;very painful.&rdquo;&nbsp;
<blockquote class="twitter-tweet">At least a few years before Starlink revenue is reasonably predictable. Going public sooner than that would be very painful. Will do my best to give long-term Tesla shareholders preference.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1407877220543180800?ref_src=twsrc%5Etfw">June 24, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Starlink, which is currently in the beta phase, is a SpaceX venture designed to beam down the internet, especially in remote areas from satellites in orbit to Earth.&nbsp;
See Also: <a href="https://www.benzinga.com/news/21/02/19576521/starlink-begins-taking-preorders-musk-eyes-ipo-when-cash-flow-predictable?utm_source=dlvr.it&amp;utm_medium=facebook" style="text-decoration:none">Starlink Begins Taking Preorders, Musk Eyes IPO When Cash Flow Predictable</a>
SpaceX offers the service at $99 a month and an additional $499 one-time cost for the kit that includes a user terminal and Wi-Fi router to connect to the satellites.
In May this year, the company claimed it had secured more than 500,000 orders for its super-fast, satellite-based internet service Starlink.
See Also: <a href="https://www.benzinga.com/news/21/05/20955576/starlink-has-received-over-500-000-orders-elon-musk-says-challenge-will-be-when-internet-service-has" style="text-decoration:none">Starlink Has Received Over 500,000 Orders; Elon Musk Says Challenge Will Be When Internet Service Has &#39;Several Million&#39; Users</a>
Why It Matters: Musk told reporters in 2019 that Starlink could generate $30 billion a year in revenue, making the company a hot target for a potential IPO.
Starlink has launched over 1,000 satellites and hopes to have 4,425 in orbit by 2024. The FCC has approved 11,943 satellites to be launched by Starlink.
Musk had in September last year said <a href="http://said">retail investors</a> would get top priority in the Starlink IPO.&nbsp;
Interest in the space-based internet network is on the rise as more companies are looking into the capabilities. Defense contractor&nbsp;Lockheed Martin Corp&rsquo;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmt#NYSE">LMT</a>) space unit has tied up with Omnispace LLC to roll out something similar and in direct competition with SpaceX.
Price Action: Tesla shares closed 5.3% higher at $656.57 on Wednesday.
For news coverage in French, Italian, or Spanish, check out&nbsp;<a href="https://fr.benzinga.com/" rel="noopener noreferrer" target="_blank">Benzinga France</a>,&nbsp;<a href="https://it.benzinga.com/" rel="noopener noreferrer" target="_blank">Benzinga Italia</a>, or&nbsp;<a href="https://es.benzinga.com/" rel="noopener noreferrer" target="_blank">Benzinga Espa&ntilde;a</a>.
Photo by Steve Jurvetson on <a href="https://www.flickr.com/photos/jurvetson/47926209216">Flickr</a>

IPOs

TSLA

Elon Musk Says Will Do His 'Best' To Give Long-Term Tesla Shareholders Preference In Starlink IPO

&nbsp;
<h3>Companies Reporting Before The Bell</h3>
&bull; GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $858.90 million.
&bull; Rite Aid (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAD#NYSE">RAD</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $6.21 billion.
&bull; Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) is expected to report quarterly earnings at $1.79 per share on revenue of $2.19 billion.
&bull; Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) is estimated to report quarterly earnings at $2.24 per share on revenue of $12.77 billion.
&bull; Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) is expected to report quarterly loss at $1.60 per share on revenue of $193.37 million.
&bull; Aesthetic Medical Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIH#NASDAQ">AIH</a>) is expected to report earnings for its first quarter.
&bull; Methode Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) is expected to report quarterly earnings at $0.70 per share on revenue of $280.05 million.
&nbsp;
<h3>Companies Reporting After The Bell</h3>
&bull; iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) is estimated to report earnings for its third quarter.
&bull; Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) is likely to report quarterly loss at $0.20 per share on revenue of $370.00 thousand.
&bull; FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) is estimated to report quarterly earnings at $4.99 per share on revenue of $21.51 billion.
&bull; Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is expected to report quarterly earnings at $0.51 per share on revenue of $11.01 billion.
&bull; Fuwei Films (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFHL#NASDAQ">FFHL</a>) is expected to report earnings for its first quarter.
&bull; BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) is estimated to report earnings for its first quarter.
&bull; Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) is likely to report quarterly earnings at $1.93 per share on revenue of $4.96 billion.
&bull; Progress Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) is expected to report quarterly earnings at $0.72 per share on revenue of $121.86 million.
&bull; CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) is estimated to report quarterly earnings at $0.07 per share on revenue of $80.25 million.

AEMD

CAMP

FFHL

PRGS

Earnings Scheduled For June 24, 2021

Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) will launch two lower-end iPhones with larger screens next year, as per analyst Ming-Chi Kuo.
What Happened:&nbsp;Apple&rsquo;s lineup in the second half of 2022 will include two iPhone lines with 6.7-inch screens &mdash; one will&nbsp;serve the low-end market and another will cater to the premium one, Kuo said, as per <a href="http://9to5mac.com/2021/06/23/kuo-2022-iphones-could-feature-under-display-touch-id-lowest-price-ever-for-6-7-inch-iphone/">9to5Mac.</a>&nbsp;Both these models will also be available in the 6.1-inch screen size.
According to the report, Kuo believes the 2022 lineup will have under-display fingerprint support and it will be available at the most affordable price point for a large screen and expected to be under $900.&nbsp;
The current iPhone lineup includes the 6.7-inch iPhone 12 Pro Max, which is priced at $1,099. Kuo said the 2022 lineup could be named iPhone 14, iPhone 14 Pro, and iPhone 14 Pro Max.&nbsp;
See Also: <a href="https://www.benzinga.com/tech/21/05/21299108/tsm-starts-production-of-a15-bionic-chip-for-apple-iphone-13-report" style="text-decoration:none">TSM Starts Production of A15 Bionic Chip For Apple iPhone 13: Report</a>
Why It Matters: Apple&rsquo;s iPhone 12 Pro Max, launched last year, is its biggest phone to-date. The company&rsquo;s yet-to-be-announced 2021 lineup is expected to sport the same variants as its predecessor from last year and the big changes will only be revealed next year, as per reports.
Price Action: Apple shares closed 0.2% lower at $133.70 on Wednesday.
For news coverage in French, Italian, or Spanish, check out&nbsp;<a href="https://fr.benzinga.com/" rel="noopener noreferrer" target="_blank">Benzinga France</a>,&nbsp;<a href="https://it.benzinga.com/" rel="noopener noreferrer" target="_blank">Benzinga Italia</a>, or&nbsp;<a href="https://es.benzinga.com/" rel="noopener noreferrer" target="_blank">Benzinga Espa&ntilde;a</a>.

Analyst Color

Media

A 6.7-Inch iPhone At $900? Analyst Says Apple Will Bring This Product To Market Next Year

CNBC host Jim Cramer believes biotechnology company Moderna Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) is an &ldquo;excellent company and stock&rdquo; that has a reach far beyond COVID-19. &nbsp;
What Happened: Cramer made the comments on Twitter.
<blockquote class="twitter-tweet">let me just say, though, i think Moderna will do far more than covid and is an excellent company and stock.
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1407729659689775105?ref_src=twsrc%5Etfw">June 23, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>On CNBC&rsquo;s &ldquo;Mad Money Lightning Round&rdquo; earlier this month, Cramer <a href="https://www.cnbc.com/2021/06/07/cramer-lightning-round-i-prefer-moderna-stock-over-novavax-.html">said</a> he prefers Moderna stock over Novavax Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>).
&ldquo;I have to tell you even after today&rsquo;s run in Moderna, I still prefer Moderna&rsquo;s stock than Novavax because I think that Moderna can do a lot more with its formulation than Novavax ever can,&rdquo; Cramer said.
See Also: <a href="https://www.benzinga.com/general/biotech/21/06/21681212/the-daily-biotech-pulse-gemini-sinks-on-data-amgens-migraine-drug-approved-in-japan-liver-congres">The Daily Biotech Pulse: Gemini Sinks On Data, Amgen&#39;s Migraine Drug Approved In Japan, Liver Congress Gets Underway</a>
Why It Matters: Shares of Moderna and other COVID-19 vaccine companies &ndash; Pfizer Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>) and its German partner BioNTech SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntx#NASDAQ">BNTX</a>) - <a href="https://www.benzinga.com/general/biotech/21/06/21690245/moderna-pfizer-stocks-fall-after-cdc-panel-flags-heart-inflammation-risk-in-young-adults-receivin">fell</a> in Wednesday&rsquo;s trading session after a report prepared by a CDC safety group warned about the risk of heart inflammation in young adults receiving COVID-19 vaccines.
Both Moderna and Pfizer-BioNTech recently received authorizations for use of their mRNA vaccines in adolescents. Revenue from the COVID-19 vaccines has&nbsp;significantly contributed to the companies&#39; top-line growth.
Meanwhile, Novavax is on the verge of getting conditional approval for its coronavirus vaccine candidate, NVX-CoV2373. The company recently reported positive results for the U.S. leg of the Phase 3 trial of its vaccine candidate.
Price Action: Moderna shares closed 4.2% lower in Wednesday&rsquo;s trading session at $212.04.
Read Next: <a href="https://www.benzinga.com/general/biotech/21/06/21639499/14-biotech-stocks-to-watch-over-the-next-6-months">14 Biotech Stocks To Watch Over The Next 6 Months</a>
Photo by Governor Tom Wolf on <a href="https://www.flickr.com/photos/governortomwolf/51125723669/">Flickr</a>

Biotech

General

BNTX

MRNA

NVAX

Jim Cramer Says Moderna 'Excellent Company And Stock' With Reach Beyond COVID-19

Michael Burry &mdash; hedge fund manager, investor, and physician&mdash; has repeated his bearish stance on <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="text-decoration-line:none">Bitcoin</a> (CRYPTO: BTC) days after issuing a&nbsp;grim warning, which prophesied losses on trendy assets&nbsp;approaching &ldquo;the size of countries.&rdquo;
What Happened: Burry issued the latest warning on Twitter and alluded to a bear trap, which is a technical pattern that incorrectly signals a reversal of a rising price trend.
See Also: <a href="https://www.benzinga.com/money/how-to-buy-bitcoin/" style="text-decoration-line:none">How To Buy Bitcoin (BTC)</a>
This can in turn lead investors to adopt long positions in expectation of price movements that do not take place.
<blockquote class="twitter-tweet">Trapped bulls often fall for the latest support. <a href="https://t.co/qshcUvpEKQ">pic.twitter.com/qshcUvpEKQ</a>
&mdash; Cassandra (@michaeljburry) <a href="https://twitter.com/michaeljburry/status/1407864102270078980?ref_src=twsrc%5Etfw">June 24, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Bitcoin traded 4.37% in the red at $32,807.51 at press time. The apex cryptocurrency is down 15.53% for the week and has plummeted 49.43% since touching an all-time high of $64,863.10 in April.
Why It Matters: On Monday, Burry<a href="https://www.benzinga.com/news/21/06/21638299/michael-burry-issues-grim-warning-on-cryptocurrency-stonks-losses-will-approach-the-size-of-countrie" style="text-decoration-line:none"> warned investors about mega losses</a> arising from the decline of cryptocurrencies and stonks, which is a reference to stocks favored by retail investors on Reddit.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21560924/dogecoin-bear-barry-silbert-says-99-of-cryptocurrencies-are-overpriced" style="text-decoration-line:none">Dogecoin Bear Barry Silbert Says 99% Of Cryptocurrencies Are Overpriced</a>
&ldquo;All hype/speculation is doing is drawing in retail before the mother of all crashes,&rdquo; Burry said in his posts as per Bloomberg. These Twitter posts have since then been deleted.
In January, Burry <a href="https://www.benzinga.com/news/21/01/19337273/gamestop-investor-michael-burry-of-the-big-short-fame-dubs-rally-unnatural-insane-and-dangerous" style="text-decoration-line:none">criticized retail investors</a> that participated in the GameStop Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) short squeeze.
He had said at the time that there should be &ldquo;legal and regulatory repercussions&rdquo; and called the actions of the investors &ldquo;unnatural, insane, and dangerous.&rdquo;
Burry, who became famous after making billions after betting against mortgage securities during the 2008 financial crisis, was played by Christian Bale in the film &ldquo;The Big Short.&rdquo;&nbsp;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21677843/has-bitcoin-found-the-bottom-at-29-000" style="text-decoration-line:none">Has Bitcoin Found The Bottom At $29,000?</a>

Short Ideas

'The Big Short' Fame's Michael Burry Takes Bearish Stand On Bitcoin After Earlier Warning On 'Mother Of All Crashes'

Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) is working with New York Magazine in a journalism project with connections to Apple News, David Hasell, the Editor-in-Chief of New York Magazine revealed in a WWD <a href="https://wwd.com/business-news/media/media-people-david-haskell-new-york-magazine-1234847582/" style="text-decoration-line:none">interview</a> this week.
What Happened: Hasell was asked if Apple News helped the magazine&rsquo;s focus on subscriptions even though it did not help the New York Times Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyt#NYSE">NYT</a>).
&ldquo;We&rsquo;re working with Apple right now on a journalism project together and that has unlocked some opportunities for us,&rdquo; said Hasell.
&ldquo;It seems to be fairly consistent with the larger strategy of thinking about this place as a subscription business, but I don&rsquo;t think Apple News has been a game changer for us.&rdquo;
Apple Shares closed 0.21% lower at $133.70 in the regular session on Wednesday.
Why It Matters: This month, it was <a href="https://www.benzinga.com/government/21/06/21425027/german-competition-watchdog-initiates-inquiry-in-googles-news-showcase-platform-reuters" style="text-decoration-line:none">reported</a> that the German competition authority has begun an investigation into Apple rival and Alphabet Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) subsidiary Google&rsquo;s News Showcase platform.
See Also: <a href="https://www.benzinga.com/news/21/05/21209628/apples-business-model-is-to-sell-overpriced-obsolete-hardware-iphone-users-are-digital-slaves-says-t" style="text-decoration-line:none">Apple&#39;s Business Model Is To Sell &#39;Overpriced, Obsolete&#39; Hardware, iPhone Users Are &#39;Digital Slaves,&#39; Says Telegram Founder</a>
The inquiry&rsquo;s mandate is to ensure there is no discrimination between individual publishers.
Earlier this year, Google threatened to <a href="https://www.benzinga.com/government/21/01/19268237/why-google-is-threatening-to-deprive-australians-of-its-search-engine" style="text-decoration-line:none">deprive Australians of its search engine</a> if the government went ahead with implementing a law that would have forced it to pay local media for content.
The search engine giant later rolled out its <a href="https://www.benzinga.com/news/21/02/19507172/google-rolls-out-paid-news-showcase-platform-to-bypass-australia-content-law" style="text-decoration-line:none">News Showcase Platform</a> in Australia in an effort to bypass the law.
Read Next: <a href="https://www.benzinga.com/news/21/06/21678110/microsoft-joins-apple-in-the-2t-valuation-club" style="text-decoration-line:none">Microsoft Joins Apple In The $2T Valuation Club</a>
&nbsp;

GOOG

GOOGL

Apple Working On A 'Journalism Project' With New York Magazine

<a href="https://www.benzinga.com/markets/cryptocurrency/21/02/19606989/what-is-cardano" style="text-decoration-line:none">Cardano</a> (CRYPTO: ADA) founder and Ethereum (CRYPTO: ETH) co-founder Charles Hoskinson said in an <a href="https://youtu.be/FKh8hjJNhWc" style="text-decoration-line:none">interview</a> that he hopes Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) CEO Elon Musk&rsquo;s <a href="http://www.benzinga.com/markets/cryptocurrency/21/05/21119489/elon-musk-working-with-dogecoin-devs-to-improve-system-transaction-efficiency">development initiatives</a> on Dogecoin (DOGE) would give the currency a &ldquo;value floor.&rdquo;
What Happened: Hoskinson in conversation with podcast host Lex Fridman this week said, &ldquo;Dogecoin is a reasonable target for someone to fix it up and make it an interesting cryptocurrency.&rdquo;
See Also: <a href="https://www.benzinga.com/money/how-to-buy-dogecoin-doge/" style="text-decoration-line:none">How To Buy Dogecoin (DOGE)</a>
Hoskinson said he hoped that a &ldquo;compromise can be made where real developers come in and they start working on DOGE to create some use and utility for it so at least it has a value floor and won&#39;t collapse.&rdquo;
Notably, Hoskinson said during the podcast that he was not against the idea of Dogecoin and Cardano working together. He said, &ldquo;it would be a lot of fun.&rdquo;
DOGE traded 9.29% higher at $0.228 at press time over 24 hours. The Shiba Inu-themed cryptocurrency was up 8.6% against both&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="text-decoration-line:none">Bitcoin</a> (CRYPTO: BTC) and ETH.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21424614/vitalik-buterin-says-he-loves-doge-suggests-dogecoin-ethereum-collaboration-for-scalabilit">Vitalik Buterin Says He Loves &#39;Doge,&#39; Suggests Dogecoin-Ethereum Collaboration For Scalability</a>
Why It Matters: Hoskinson said no matter whoever &ldquo;comes in&rdquo; improvements to Dogecoin will require 2-3 years of work.&nbsp;
Last month, Hoskinson had released a video directed at Musk on <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21190100/elon-musk-gets-schooled-by-ethereum-co-founder-on-how-to-improve-dogecoin" style="text-decoration-line:none">how to improve Dogecoin</a>. The video featured almost a dozen papers on transaction speed, quantum resistance, smart contracts, and more.&nbsp;
Musk had asked his social media following for help for improvements to DOGE and asked them to <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21271060/dogecoin-subreddit-crosses-2-million-subshibers-after-elon-musks-call-for-help" style="text-decoration-line:none">submit their ideas</a> on GitHub and Reddit.
Dogecoin co-creator Billy Markus said in April that the <a href="https://www.benzinga.com/markets/cryptocurrency/21/04/20761872/dogecoin-creator-says-meme-coins-development-has-kept-pace-with-bitcoin" style="text-decoration-line:none">meme coin&rsquo;s development</a> has kept pace with Bitcoin. This month, Markus said of Musk&#39;s <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21504329/exclusive-dogecoin-co-creator-on-development-efforts-says-no-knock-on-elon-others-but-acti" style="text-decoration-line:none">DOGE development efforts</a> that he was &ldquo;not super excited about people talking about doing things, only people actually doing things.&rdquo;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21621259/exclusive-dogecoin-mania-didnt-prove-the-end-of-crypto-so-they-launched-commercial-toilet-" style="text-decoration-line:none">EXCLUSIVE: Dogecoin Mania Didn&#39;t Prove &#39;The End Of Crypto,&#39; So They Launched Commercial Toilet Paper-Backer Tetherino, &#39;The Most Ridiculous Cryptocurrency&#39; Ever</a>

$ADA

Elon Musk's Development Efforts Could Give Dogecoin A 'Value Floor,' Hopes Cardano Founder

Electric vehicle maker Tesla Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) has emerged as one of the most discussed names on Reddit&rsquo;s r/WallStreetBets forum, while Clover Health Investments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>), ContextLogic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wish#NASDAQ">WISH</a>) &nbsp;and Workhorse Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wkhs#NASDAQ">WKHS</a>) are seeing the highest interest from retail investors.
What Happened: Medical insurance technology company Clover Health has emerged as the most-discussed stock on the forum with 1,047 mentions during the last 24 hours at press time, data from Quiver Quantitative showed.
ContextLogic, an e-commerce company that operates the Wish platform, took the second spot with 794 mentions, followed by electric vehicle maker Workhorse Group with 617 mentions.
Apart from Tesla, the other stocks that are trending on the forum include movie theatre chain AMC Entertainment Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>), renewable natural gas company Clean Energy Fuels Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clne#NASDAQ">CLNE</a>) and&nbsp;videogame retailer GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>).&nbsp;
See Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/21/06/21692399/tesla-and-nvidia-lead-the-nasdaq-in-a-mixed-day-of-trading">Tesla And Nvidia Lead The Nasdaq In A Mixed Day Of Trading</a>
Why It Matters: Clover Health and Wish continue to attract the attention of retail investors,&nbsp;with many touting them as the next short squeeze candidates.
Workhorse Group and Tesla are seeing increased interest from the WSB forum after their shares surged on Wednesday. It was <a href="https://www.benzinga.com/tech/21/06/21687631/tesla-energy-goes-to-china-bringing-solar-and-powerwall">reported</a> earlier in the day that Tesla plans to bring sustainable energy production and storage to China, starting with the rollout of Powerwall in the country.
Price Action: Clover Health shares closed 9.5% higher in Wednesday&rsquo;s regular trading session at $13.83 and further rose almost 1.9% in the after-hours session to $14.09.
ContextLogic shares closed 0.8% higher in the regular trading session at $13.61 and further rose almost 0.3% in the after-hours session to $13.65.
Workhorse shares closed 9.4% higher in the regular trading session at $15.91, but declined 0.4% in the after-hours session to $15.84.
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/21/06/21688109/former-wall-street-floor-trader-tesla-is-going-to-700">Former Wall Street Floor Trader: Tesla Is Going To $700</a>

Long Ideas

CLNE

CLOV

WISH

WKHS

Tesla Joins Top WallStreetBets Interests As Stock Surges; Clover Health Tops The Chart

Shares of Sundial Growers Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) closed more than 12% higher in Wednesday&rsquo;s regular trading session and further gained 1% in the extended session.
What Happened: While there was no company-specific news that contributed to the surge in Sundial&rsquo;s shares, the cannabis company is a frequently mentioned stock on Reddit&rsquo;s r/WallStreetBets forum that has 10.6 million members.
See also: <a href="https://www.benzinga.com/money/how-to-buy-sundial-growers-sndl-stock/">How To Buy Sundial Growers (SNDL) Stock</a>
The retail investment forum is best known for short squeezes on companies such as GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) and AMC Entertainment Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) earlier this year.
About 14.4% of Sundial&rsquo;s float is short, as per the latest available data from Yahoo! Finance. The company is seeing increased interest from retail investors as more states in the U.S. pass laws and legislation to legally allow the sale and use of marijuana.
See Also: <a href="https://www.benzinga.com/markets/cannabis/21/06/21685173/cannabis-legalization-on-the-move-rhode-island-senate-approves-louisiana-gov-says-yes-to-smokabl?itm_source=parsely-api">Cannabis Legalization On the Move: Rhode Island Senate Approves, Louisiana Gov. Says Yes To Smokable Medical Marijuana</a>
Why It Matters: Sundial Growers attracted 144 mentions on the WSB forum and was the fifteenth most-discussed stock during the last 24 hours at press time, data from Quiver Quantitative showed.
Retail investors behave differently than institutional investors, and this offers a number of opportunities for a company like Sundial, the company&#39;s CEO Zach George said at the <a href="http://www.benzinga.com/markets/cannabis/21/06/21433673/exclusive-sundial-ceo-says-support-of-retail-investors-key-to-turnaround">Benzinga Cannabis Conference</a> earlier this month.
Taking advantage of the investor interest, Sundial said in January that it is raising $100 million through a sale of stock and warrants.
Price Action: Sundial shares closed 12.2% higher in Monday&rsquo;s regular trading session at $1.00 and further rose 1% in the after-hours session to $1.01.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/21/06/21686949/cannabis-mergers-canopy-growth-issues-9-million-shares-to-complete-acquisition-of-supreme-cannab?itm_source=parsely-api">Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.</a>

Cannabis

Penny Stocks

Movers

SNDL

What's Going On With Sundial Growers Stock?

Roku Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roku#NASDAQ">ROKU</a>) shares shot up over 4.5% and ViacomCBS Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viac#NASDAQ">VIAC</a>) shares were up over 2.6% at the end of the regular session on Wednesday.
What Happened: The movement in the stock prices was fueled by a <a href="https://www.wsj.com/articles/comcasts-ceo-built-a-cable-giant-can-he-build-a-streaming-giant-11624473722?mod=searchresults_pos1&amp;amp;page=1" style="text-decoration-line:none">report</a> from The Wall Street Journal that Comcast Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NASDAQ">CMCSA</a>) CEO Brian Roberts is eyeing a possible collaboration with ViacomCBS or acquiring Roku in a bid to buttress the company&rsquo;s future in streaming.
A Comcast spokesperson dismissed the report as speculation, CNBC <a href="https://www.cnbc.com/2021/06/23/viacomcbs-roku-shares-jump-on-report-that-comcast-is-considering-deal.html" style="text-decoration-line:none">reported</a>.&nbsp;
On Wednesday evening, Roku shares rose 4.5% to $421.70 in the regular session and another 0.5% in the after-hours trading. On the same day, ViacomCBS shares closed 2.67% higher in the regular session at $41.84 and rose another almost 0.6% in after-hours trading.
Comcast shares closed 3.73% lower at $55.48 in the regular session on Wednesday and gained 0.13% in the after-hours trading.
Why It Matters: The Journal noted that Comcast subsidiary NBCUniversal&rsquo;s Peacock service is lagging rivals such as Netflix Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>) and The&nbsp;Walt Disney Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) in terms of paid subscribers.
In late April, while Peacock had <a href="https://www.benzinga.com/news/21/04/20872581/comcasts-peacock-reaches-42m-subscribers-thanks-to-wwe-the-office" style="text-decoration-line:none">42 million sign-ups</a>, in May it had fewer than 10 million paid subscribers. Netflix and Disney&#39;s numbers amounted to 208 million and 103.6 million globally in the first quarter.
Comcast&rsquo;s streaming plans also span a partnership with Walmart Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wmt#NYSE">WMT</a>) and Chinese firm Hisense Home Appliances Group Co, Ltd (OTC: <a class="ticker" href="https://www.benzinga.com/stock/hisef#OTC">HISEF</a>) for the development of smart televisions, which could appear in stores later this year, as per the Journal.
Meanwhile, NBCUniversal CEO Jeff Shell said this month that depending on the ratings, the soon-to-be-held Tokyo Summer Olympics could be &ldquo;the <a href="https://www.benzinga.com/news/21/06/21628889/could-the-2020-olympics-see-record-profits-for-comcast" style="text-decoration-line:none">most profitable for the company.</a>&rdquo;
Read Next: <a href="https://www.benzinga.com/news/21/06/21409929/walmart-is-now-getting-into-streaming-hardware-how-will-the-move-impact-roku-partnership" style="text-decoration-line:none">Walmart Is Now Getting Into Streaming Hardware: How Will The Move Impact Roku Partnership?</a>
Photo by <a href="https://www.flickr.com/photos/149887304@N05/33394021904">roku Activate</a> on Flickr

CMCSA

HISEF

NFLX

ROKU

VIAC

What's Up With Roku, ViacomCBS Stocks

Dogecoin (CRYPTO: DOGE) traded 20% higher at press time over 24 hours, making to the list of top gainers as the global cryptocurrency market cap rose 8% to $1.35 trillion on Wednesday night.
What Happened: DOGE traded 20% higher at $0.23 at press time and was up 25.21% and 22.07% against <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="text-decoration-line:none">Bitcoin</a> (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) respectively.
See Also: <a href="https://www.benzinga.com/money/how-to-buy-dogecoin-doge/" style="text-decoration-line:none">How To Buy Dogecoin (DOGE)</a>
Even so, the Shiba Inu-themed cryptocurrency is still down 24.61% over the week.
The apex cryptocurrency, BTC, traded 1.18% lower at $33,331.15 at press time over 24 hours, for the week it has declined 13.77%.
ETH recorded a gain of 0.46% and traded under the psychologically $2,000 mark at $1,940.95 over 24 hours. For the week, it is down 19.06%.
Ankr (CRYPTO: ANKR), the token of the Web3 infrastructure platform, was the top gainer on Wednesday night soaring 47.8% at $0.08. The token was up 42.9% and 39.31% against BTC and ETH over 24 hours.
Other notable gainers included The Graph (CRYPTO: GRT), XRP (CRYPTO: XRP), and Tron (CRYPTO: TRX).&nbsp;
The Graph was up 26.64% at $0.615, XRP rose 13.56% to $0.64, and Tron spiked 17.68% to $0.062 over 24 hours.
Why It Matters: The short squeeze rally seen in Bitcoin appears to be fizzling out with analysts split on whether the cryptocurrency has found a bottom.
&ldquo;It&rsquo;s too early to tell if this is &lsquo;the&rsquo; bottom or just a temporary floor before more downside,&rdquo; said Elie Le Rest, the co-founder of crypto hedge fund ExoAlpha, <a href="https://www.coindesk.com/market-wrap-bitcoin-rally-regulatory-risk" style="text-decoration-line:none">reported</a> CoinDesk.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21677843/has-bitcoin-found-the-bottom-at-29-000" style="text-decoration-line:none">Has Bitcoin Found The Bottom At $29,000?</a>
&quot;The lack of any upside catalyst (beside some contrarian oversold metrics) remains the biggest hurdle for cryptos to bounce back.&rdquo;
Delta Exchange CEO Pankaj Balani reportedly said he does not expect the apex coin to break the $30,000 support.
&ldquo;Naked shorts have started to enter the market and the risk of sharp rises due to short squeezes is higher.&rdquo;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21678479/elon-musks-dogecoin-donation-helped-63-people-financially-hit-by-covid-19-says-charity" style="text-decoration-line:none">Elon Musk&#39;s Dogecoin Donation Helped 63 People Financially Hit By COVID-19, Says Charity</a>

$ETH

$TRX

$XRP

Dogecoin Surges 20% As Market Recovers, Ethereum Hovers Below $2,000

Roth Capital analyst Gerry Sweeney initiates coverage on PureCycle Technologies (NASDAQ:<a class="ticker" href="/stock/PCT#NASDAQ">PCT</a>) with a Buy rating and announces Price Target of $45.

Initiation

Roth Capital Initiates Coverage On PureCycle Technologies with Buy Rating, Announces Price Target of $45

Downgrades

Intraday Update

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021

WIIM

PureCycle Technologies shares are trading after Roth Capital initiated coverage on the stock with a Buy rating and a price target of $45 per share.

Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO <a href="https://www.joinclubhouse.com/@downtownjbrown">Josh Brown</a> and Benzinga CEO <a href="https://www.joinclubhouse.com/@jasonraznick">Jason Raznick</a> host &quot;The Boiler Room,&quot; a Clubhouse audio chat where listeners can pitch their favorite stock.

Here are this week&#39;s pitches.

PureCycle Technologies (NASDAQ:<a class="ticker" href="/stock/PCT#NASDAQ">PCT</a>)

Pure Cycle removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene.

David (@davidalston2) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>The potential for ESG-fund inclusion.</li>
	<li>Building plants, spending on growth.</li>
	<li>Patented product, monopoly situation.</li>
</ul>

&quot;What kind of business are they doing currently,&quot; Brown asked

&quot;They have revenue, currently at 50% EBITDA,&rdquo; David responded. &ldquo;This is something that is just getting started and they will probably not have GAAP profits for a while because they will have to build plants.&rdquo;

Forest Road Acquisition Corporation (NYSE:<a class="ticker" href="/stock/FRX#NYSE">FRX</a>)

Forest Road is a special purpose acquisition company that will take The Beachbody Company, a fitness, and media company.

Sameer (@commitwithmeer) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Launched subscription streaming.</li>
	<li>SPAC-mania no more, price is low.</li>
	<li>On-demand access to top trainers.</li>
</ul>

&quot;Why is Beachbody going to win if there are so many different streaming platforms for fitness,&quot; asked Brown.

&quot;When you go to Peleton or Apple, you&rsquo;re not going for an all-in-one-stop shop,&rdquo; Sameer answered. &ldquo;With Beachbody, it is a one-stop-shop. I&rsquo;m paying a monthly fee, I can get a coach if I want to. On top of that, there are new workouts from celebrity coaches, and I can get shakes and supplements, too.&rdquo;

Uber Technologies Inc (NYSE:<a class="ticker" href="/stock/UBER#NYSE">UBER</a>)

Uber is a provider of transportation service, ride-hailing provider.

Marc (@miweber) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Move to ditch poor investments.</li>
	<li>To benefit from housing boom.</li>
	<li>Postmates acquisition paying.</li>
	<li>Uber has biggest market share.</li>
</ul>

&quot;Nice consolidation, clear uptrend, big base after the IPO,&quot; guest J.C. Parets noted.

Star Peak Energy Transition Corporation (NYSE:<a class="ticker" href="/stock/STPK#NYSE">STPK</a>)

Star Peak is a SPAC that plans to take Stem Inc, an energy solution provider, public.

Farukh (@kingrukh) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>The grid for partner companies.</li>
	<li>Uses technology to store energy.</li>
	<li>A clean and solar energy play.</li>
</ul>

&quot;How big are they,&quot; Brown asked.

&quot;Right now, their market cap is $2 billion and they have $250 million in cash,&rdquo; Farukh responded.

&ldquo;It looks like the market is very excited about the story,&rdquo; Brown added.

Fubotv Inc (NYSE:<a class="ticker" href="/stock/FUBO#NYSE">FUBO</a>)

fuboTV is a digital entertainment company.

Nick (@magicshak) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Play on sports betting, streaming.</li>
	<li>Only a few players in the space.</li>
	<li>Great for restaurant and bar TV.</li>
	<li>The short interest is nearly 50%.</li>
	<li>The big catalyst is the World Cup.</li>
	<li>Speculative play, execution story.</li>
</ul>

&quot;Why is this stock a falling knife,&quot; Brown asked.

&quot;There&rsquo;s a competitive deal. DraftKings is doing something with Dish Network and that hurt,&rdquo; Raznick responded.

Yeti Holdings Inc (NYSE:<a class="ticker" href="/stock/YETI#NYSE">YETI</a>)

YETI is a provider of goods for outdoor activities.

Kimberly (@kimberlyenders) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Reopening, outdoor living play.</li>
	<li>Stock is pegged at recent highs.</li>
	<li>Been in an uptrend since listing.</li>
</ul>

&quot;I love it,&quot; said Raznick. &quot;I went to my son&rsquo;s baseball game and everyone had Yeti&nbsp;coolers. Everything is Yeti. Dicks Sporting Goods has a Yeti&nbsp;wall, too.&quot;

Paysafe (NYSE:<a class="ticker" href="/stock/PSFE#NYSE">PSFE</a>)

Paysafe is a payments platform.

Jackson (@jacksonalacarte) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Second largest payments processor.</li>
	<li>Over $100 million in transactions.</li>
	<li>75% of gambling websites use it.</li>
	<li>Regulatory evolution is beneficial.</li>
</ul>

&quot;How come this stock isn&rsquo;t acting well,&quot; Brown asked.

&quot;What&rsquo;s great about this company is it did over $1.5 billion in revenue last year and its profit margin was 63%, which is astounding,&rdquo; Jackson responded. &ldquo;If you compare it to other fintech companies and payment processors&nbsp;&hellip; the valuation is so much lower.&rdquo;

CBS Corporation (NASDAQ:<a class="ticker" href="/stock/VIAC#NASDAQ">VIAC</a>)

CBS is a multinational mass media conglomerate.

Daniel (@doony) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Stock is beaten down.</li>
	<li>New competitive offer.</li>
</ul>

&quot;They have a streaming app, they&rsquo;re adding people, but can they produce enough new stuff to keep people paying for it,&quot; Brown asked. &quot;You need new stuff to keep people.&rdquo;

International Business Machines Corporation (NYSE:<a class="ticker" href="/stock/IBM#NYSE">IBM</a>)

IBM is an information technology company.

Alex (@alexweiner) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>Entered into quantum computing.</li>
	<li>Break cryptography, destroy crypto.</li>
</ul>

&quot;Is IBM&rsquo;s announcement of having commercially available quantum computing and Bitcoin crashing a coincidence,&quot; Brown asked.

&quot;No,&rdquo; Alex responded.&nbsp;&ldquo;IBM is first to market and they may be onto something, innovating.&quot;

&ldquo;It&rsquo;s breaking out of a big consolidation, but it is still in a downtrend,&rdquo; Brown added.

Magnite Inc (NASDAQ:<a class="ticker" href="/stock/MGNI#NASDAQ">MGNI</a>)

Magnite is an online advertising technology company.

Alaine (@ms.alaine) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>A large provider of programmatic advertising.</li>
	<li>Algorithmically code, decide through information.</li>
	<li>Working with companies like Fox and Dish.</li>
	<li>Advertising catered to specific demographics.</li>
</ul>

&quot;More people are getting into ad-supported video,&quot; Alaine noted. &quot;Magnite has exclusive relationships with Hulu and Disney.&rdquo;

&ldquo;I love the story,&rdquo; Brown noted.

Activision Blizzard Inc (NASDAQ:<a class="ticker" href="/stock/ATVI#NASDAQ">ATVI</a>)

Activision is a video game holding company.

Mike (@themikehoward) had a bullish outlook on the stock because of the following reasons:

<ul>
	<li>New release for World of Warcraft.</li>
	<li>Three new releases for Diablo.</li>
	<li>Market not pricing in the good news.</li>
</ul>

&ldquo;I think it is going higher,&rdquo; Brown noted. &ldquo;This is a great story.&rdquo;

The 'Boiler Room' Stock Pitch Recap: PureCycle, Uber, Yeti, Paysafe, IBM And More

<a href="https://twitter.com/HindenburgRes/status/1390290802950213633" title="https://twitter.com/HindenburgRes/status/1390290802950213633">https://twitter.com/HindenburgRes/status/1390290802950213633</a>

Short Sellers

'NEW FROM US: PureCycle—The Latest Zero-Revenue ESG SPAC Charade, Sponsored By The Worst Of Wall Street' -Tweet From Short Seller Hindenburg Research

PureCycle Technologies Shares Resume Trading; Down 27%

Following the market opening Thursday, the Dow traded down 0.03% to 34,218.62 while the NASDAQ fell 0.70% to 13,487.34. The S&amp;P also fell, dropping 0.31% to 4,154.86.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,558,060 cases with around 579,280 deaths. India confirmed a total of at least 21,077,410 cases and 230,160 deaths, while Brazil reported over 14,930,180 COVID-19 cases with 414,390 deaths. In total, there were at least 155,261,330 cases of COVID-19 worldwide with more than 3,243,960 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Consumer staples shares rose 0.7% on Thursday. Meanwhile, top gainers in the sector included Ambev S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABEV#NYSE">ABEV</a>), up 8%, and Kellogg Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>), up 6%.

 
In trading on Thursday, energy shares fell 1.5%.

 
Top Headline

Kellogg Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) reported <a href="https://www.benzinga.com/news/earnings/21/05/20981905/earnings-scheduled-for-may-6-2021/"> better-than-expected</a> earnings for its first quarter and raised its FY21 guidance.

Kellogg reported quarterly earnings of $1.11 per share, beating analysts&rsquo; estimates of $0.96 per share. The company&rsquo;s quarterly sales came in at $3.58 billion, versus expectations of $3.38 billion.

Kellogg raised its FY21 organic net sales guidance from down 1% to flat on year-over-year basis. The company also boosted adjusted EPS growth guidance from 1% year over year to up 1-2% year over year.

&nbsp;

Equities Trading UP

 
SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares shot up 54% to $8.47 on above-average volume.

 
Shares of Lexaria Bioscience Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) got a boost, shooting 35% to $6.81 after the company disclosed successful results from first 2021 study, HYPER-A21-1.

 
Sally Beauty Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) shares were also up, gaining 22% to $24.68 after the company reported better-than-expected Q2 results.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

James River Group Holdings, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) shares tumbled 31% to $31.97 after the company swung to a loss in the first quarter. The company also priced its 5.65 million share common stock offering at $31 per share.

Shares of Yellow Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YELL#NASDAQ">YELL</a>) were down 31% to $6.62 after the company reported worse-than-expected Q1 EPS results.

PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) was down, falling 34% to $16.33.

 
Commodities

 
In commodity news, oil traded down 0.5% to $65.28, while gold traded up 0.4% to $1,790.70.

 
Silver traded up 1% Thursday to $26.78 while copper rose 0.8% to $4.5615.

 
Euro zone

European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 slipped 0.1%, the Spanish Ibex Index fell 0.2% and the German DAX 30 gained 0.1%. Meanwhile, the London&rsquo;s FTSE 100 gained 0.1%, French CAC 40 rose 0.1% and Italy&rsquo;s FTSE MIB gained 0.3%.

The IHS Markit Eurozone&rsquo;s construction PMI came in unchanged at 50.1 in April, while French construction PMI rose to 49.8 in April from 49.7 in the earlier month. The IHS Markit/CIPS UK composite PMI increased to 60.7 in April versus a preliminary reading of 60.

German construction PMI dropped to 46.2 in April versus 47.5 in the prior month, while factory orders rose 3.0% in March.

 
Economics

 
US initial jobless claims fell by 92,000 to 498,000 in the week ending May 1st.

 
Nonfarm labor productivity increased by an annualized 5.4% in the first quarter, while unit labor costs dropped an annualized 0.3%.

 
The Energy Information Administration&rsquo;s weekly report on natural gas stocks in underground storage is scheduled for release at 10:30 a.m. ET.

 
The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.

 
Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 1:00 p.m. ET.

 
Federal Reserve Bank of Cleveland President Loretta Master will speak at 1:00 p.m. ET.

 
Federal Reserve Bank of Dallas President Robert Kaplan is set to speak at 6:05 p.m. ET.

<a href="https://www.benzinga.com/calendar/economics/">Check out the full economic calendar here </a>

Eurozone

Commodities

Global

Mid-Morning Market Update: Markets Mostly Lower; Kellogg Earnings Beat Views

<h3>Gainers</h3>

<ul>
	<li>Stealth BioTherapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITO#NASDAQ">MITO</a>) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology meeting with positive data from a post hoc analysis of the Phase 1 ReCLAIM study evaluating elamipretide in patients with non-central geographic atrophy and high risk drusen associated with dry age-related macular degeneration.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares jumped 45% to $7.97 on above-average volume.</li>
	<li>Lexaria Bioscience Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) gained 27.2% to $6.40 after the company disclosed successful results from first 2021 study, HYPER-A21-1.</li>
	<li>Barnwell Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRN#NYSE">BRN</a>) surged 23.8% to $3.32 on above-average volume.</li>
	<li>Summit Wireless Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) gained 20.7% to $3.4038.</li>
	<li>Sally Beauty Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) shares climbed 19.5% to $24.20 after the company reported better-than-expected Q2 results.</li>
	<li>Avid Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVID#NASDAQ">AVID</a>) gained 19.1% to $25.86 after the company reported better-than-expected Q1 results and raised FY21 guidance.</li>
	<li>Biofrontera AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRA#NASDAQ">BFRA</a>) jumped 18.3% to $6.20 after the company announced preliminary April revenue of &euro;2.491 million, up from &euro;492 thousand year over year.</li>
	<li>Liquidity Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) gained 17% to $21.95 following upbeat quarterly results.</li>
	<li>Eltek Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) jumped 17% to $7.00.</li>
	<li>At Home Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOME#NYSE">HOME</a>) shares rose 16.6% to $36.48 after the Wall Street Journal reported that private-equity firm Hellman &amp; Friedman LLC is nearing a deal to buy the company.</li>
	<li>WW International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) gained 16.4% to $32.10 following Q1 results.</li>
	<li>Orgenesis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) surged 16% to $5.20 after the company announced FDA approval of the Investigational Device Exemption for the pilot clinical trial of its Tissue Genesis Icellator2.</li>
	<li>Acushnet Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) gained 15.7% to $49.65 after reporting strong Q1 results.</li>
	<li>Hecla Mining Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) surged 14.7% to $7.17 after the company reported better-than-expected Q1 results.</li>
	<li>Taitron Components Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAIT#NASDAQ">TAIT</a>) climbed 14.2% to $4.88.</li>
	<li>Corvus Gold Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOR#NASDAQ">KOR</a>) gained 12.8% to $2.37. Corvus Gold secured $20 million loan from AngloGold Ashanti North America Inc. to fund North Bullfrog permitting and pre-development work.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) climbed 11.5% to $1.65 after dropping over 8% on Wednesday. The company last week received a Nasdaq notification letter indicating shares will be suspended May 9. The company plans to appeal the determination.</li>
	<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) gained 11% to $2.44.</li>
	<li>MoSys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOSY#NASDAQ">MOSY</a>) gained 10.8% to $4.22.</li>
	<li>SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) rose 9.9% to $3.3350 after surging around 30% on Wednesday.</li>
	<li>JanOne Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAN#NASDAQ">JAN</a>) rose 8.7% to $7.50 after gaining over 7% in the previous session.</li>
	<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) rose 5.6% to $44.19 after the company reported better-than-expected Q1 sales.</li>
	<li>Anheuser-Busch InBev SA/NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) rose 5.5% to $74.53 following quarterly results.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>James River Group Holdings, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) shares dipped 32% to $31.60 after the company swung to a loss in the first quarter. The company also priced its 5.65 million share common stock offering at $31 per share.</li>
	<li>Yellow Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YELL#NASDAQ">YELL</a>) fell 31.8% to $6.52 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) dropped 31.3% to $16.90.</li>
	<li>Regis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGS#NYSE">RGS</a>) fell 24.3% to $9.11 after reporting downbeat Q3 results.</li>
	<li>Fastly, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NASDAQ">FSLY</a>) shares fell 23.8% to $44.25 after the company reported worse-than-expected Q1 sales. The company also announced the CFO is stepping down.</li>
	<li>U.S. Concrete, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCR#NASDAQ">USCR</a>) dipped 22.2% to $51.97 after the company reported worse-than-expected Q1 results.</li>
	<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) fell 21.3% to $15.33 after jumping 96% on Wednesday.</li>
	<li>Quotient Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUOT#NASDAQ">QUOT</a>) dipped 20.8% to $13.35 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>Home Point Capital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HMPT#NASDAQ">HMPT</a>) fell 20.3% to $7.47 following downbeat quarterly earnings.</li>
	<li>ENGlobal Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENG#NASDAQ">ENG</a>) dropped 20% to $2.56 after reporting Q1 results.</li>
	<li>Ever-Glory International Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVK#NYSE">EVK</a>) fell 19.7% to $2.45 after jumping 29% on Wednesday.</li>
	<li>Aviat Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) dipped 19.2% to $27.50 after the company reported Q3 earnings results.</li>
	<li>VYNE Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYNE#NASDAQ">VYNE</a>) dropped 17.7% to $3.72 following weak quarterly sales.</li>
	<li>Amtech Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) dipped 17% to $8.70 after reporting a Q2 loss.</li>
	<li>Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) fell 16.2% to $19.10 after the company reported worse-than-expected Q1 earnings.</li>
	<li>10x Genomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) dropped 15.9% to $153.87 following Q1 results.</li>
	<li>Redfin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) fell 15.3% to $52.70 following Q1 loss.</li>
	<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) dropped 14% to $14.85 after the company reported worse-than-expected Q1 results.</li>
	<li>Grand Canyon Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) dipped 13.8% to $92.11 after the company issued weak sales outlook.</li>
	<li>Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) shares fell 13.7% to $159.20 after the company reported Q1 earnings results.</li>
	<li>Blue Apron Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APRN#NYSE">APRN</a>) dropped 13.5% to $5.11 after the company reported Q1 results and issued weak sales forecast for the second quarter.</li>
	<li>Walker &amp; Dunlop, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WD#NYSE">WD</a>) dipped 12.1% to $99.56 following downbeat quarterly results.</li>
	<li>Intrepid Potash, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) dropped 12% to $28.86. The company recently released Q1 results.</li>
	<li>Olympic Steel, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEUS#NASDAQ">ZEUS</a>) dipped 11.9% to $30.30.</li>
	<li>Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) fell 11.7% to $84.07 after the company reported a Q1 loss.</li>
	<li>Vaxart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) fell 10.2% to $6.63 after dropping over 15% on Wednesday. Vaxart recently reported new data from its oral COVID-19 vaccine Phase I study that suggests broad cross-reactivity against other coronaviruses.</li>
	<li>Titan International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) dropped 10% to $9.99 after the company reported Q1 earnings results.</li>
	<li>Cardinal Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) fell 9.9% to $54.83 after the company reported worse-than-expected Q3 results.</li>
	<li>American Shared Hospital Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) fell 9.5% to $3.2079 after climbing more than 30% on Wednesday.</li>
	<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) fell 9.2% to $9.9. Ocugen is expected to report Q1 earnings on Friday, May 7.</li>
	<li>Synthetic Biologics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYN#NYSE">SYN</a>) declined 7.8% to $0.4665 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) shares fell 7.7% to $4.6682. Precipio recently launched its COVID-19 rapid antibody test on the Amazon.com Inc platform.</li>
	<li>Allegiant Travel Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGT#NASDAQ">ALGT</a>) dropped 6.7% to $218.24 after the company priced its 1.35 million share common stock offering at $219 per share.</li>
	<li>Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) fell 6.2% to $47.99 after the company reported Q1 earnings results.</li>
</ul>

58 Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>

<ul>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares surged 85.8% to settle at $10.22 on above-average volume.</li>
	<li>Liquidity Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) jumped 37.7% to settle at $25.83 following upbeat quarterly results.</li>
	<li>Stealth BioTherapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITO#NASDAQ">MITO</a>) shares gained 35% to close at $1.62 on Thursday. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology meeting with positive data from a post hoc analysis of the Phase 1 ReCLAIM study evaluating elamipretide in patients with non-central geographic atrophy and high risk drusen associated with dry age-related macular degeneration.</li>
	<li>Avid Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVID#NASDAQ">AVID</a>) surged 27.1% to settle at $27.59 after the company reported better-than-expected Q1 results and raised FY21 guidance.</li>
	<li>WW International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) climbed 25.9% to close at $34.73 following Q1 results.</li>
	<li>ShiftPixy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) gained 24.9% to settle at $3.01.</li>
	<li>Applied UV, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVI#NASDAQ">AUVI</a>) surged 23.2% to close at $10.47.</li>
	<li>Biofrontera AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRA#NASDAQ">BFRA</a>) climbed 22.9% to close at $6.44 after the company announced preliminary April revenue of &euro;2.491 million, up from &euro;492 thousand year over year.</li>
	<li>Lexaria Bioscience Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) rose 22.1% to close at $6.14 after the company disclosed successful results from first 2021 study, HYPER-A21-1.</li>
	<li>BioCryst Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) gained 21% to settle at $12.92 after the company reported better-than-expected Q1 sales results.</li>
	<li>At Home Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOME#NYSE">HOME</a>) shares jumped 20.5% to close at $37.70 after the Wall Street Journal reported that private-equity firm Hellman &amp; Friedman LLC is nearing a deal to buy the company.</li>
	<li>Acushnet Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) surged 20.1% to close at $51.55 after reporting strong Q1 results.</li>
	<li>Sally Beauty Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) shares jumped 20% to close at $24.32 after the company reported better-than-expected Q2 results.</li>
	<li>Nova LifeStyle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) gained 17.8% to settle at $3.18.</li>
	<li>American Shared Hospital Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) gained 16.6% to close at $4.14 after climbing more than 30% on Wednesday.</li>
	<li>Hecla Mining Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) gained 16.6% to close at $7.29 after the company reported better-than-expected Q1 results.</li>
	<li>SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) jumped 15.7% to settle at $4.28 after surging around 30% on Wednesday.</li>
	<li>Eltek Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) gained 15.5% to close at $6.93.</li>
	<li>Corvus Gold Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOR#NASDAQ">KOR</a>) jumped 14.8% to settle at $2.41. Corvus Gold secured $20 million loan from AngloGold Ashanti North America Inc. to fund North Bullfrog permitting and pre-development work.</li>
	<li>Inhibrx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBX#NASDAQ">INBX</a>) rose 14.5% to close at $16.82.</li>
	<li>Asia Pacific Wire &amp; Cable Corporation Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APWC#NASDAQ">APWC</a>) surged 13.9% to close at $3.78.</li>
	<li>1847 Goedeker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOED#NYSE">GOED</a>) surged 13.8% to close at $6.03. The company recently reported a $205 million common stock offering.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) gained 13.5% to close at $1.68 after dropping over 8% on Wednesday. The company last week received a Nasdaq notification letter indicating shares will be suspended May 9. The company plans to appeal the determination.</li>
	<li>Cross Country Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) rose 13.5% to settle at $16.11 after the company reported better-than-expected Q1 EPS and sales results and issued Q2 EPS and sales guidance above estimates.</li>
	<li>Big 5 Sporting Goods Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) jumped 13.2% to close at $28.30 on continued upward momentum after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 EPS guidance above estimates.</li>
	<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) gained 12.5% to close at $6.65 after the company reported better-than-expected Q2 sales results.</li>
	<li>AxoGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) jumped 12.5% to settle at $22.09 after the company reported better-than-expected Q1 results. The company also issued FY21 sales guidance above estimates.</li>
	<li>Barnwell Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRN#NYSE">BRN</a>) gained 12.3% to close at $3.01 on above-average volume.</li>
	<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) rose 11.7% to settle at $46.73 after the company reported better-than-expected Q1 sales.</li>
	<li>JanOne Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAN#NASDAQ">JAN</a>) rose 11.6% to close at $7.70 after gaining over 7% in the previous session.</li>
	<li>Taitron Components Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAIT#NASDAQ">TAIT</a>) rose 8.1% to close at $4.6150.</li>
	<li>Anheuser-Busch InBev SA/NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) rose 6.2% to close at $75.00 following quarterly results.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) shares fell 39.7% to close at $14.83 on Thursday.</li>
	<li>Yellow Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YELL#NASDAQ">YELL</a>) shares dipped 31.9% to settle at $6.51 on Thursday after the company reported worse-than-expected Q1 EPS results.</li>
	<li>Fastly, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NASDAQ">FSLY</a>) shares fell 27.1% to settle at $42.31 after the company reported worse-than-expected Q1 sales. The company also announced the CFO is stepping down.</li>
	<li>James River Group Holdings, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) shares tumbled 26.4% to close at $34.23 on Thursday after the company swung to a loss in the first quarter. The company also priced its 5.65 million share common stock offering at $31 per share.</li>
	<li>Quotient Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUOT#NASDAQ">QUOT</a>) dipped 25.1% to close at $12.64 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>ENGlobal Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENG#NASDAQ">ENG</a>) dipped 25% to close at $2.40 after reporting Q1 results.</li>
	<li>Ever-Glory International Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVK#NYSE">EVK</a>) dropped 23.3% to close at $2.34 after jumping 29% on Wednesday.</li>
	<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) fell 23.1% to close at $14.98 after jumping 96% on Wednesday.</li>
	<li>VYNE Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYNE#NASDAQ">VYNE</a>) dropped 21.2% to settle at $3.56 following weak quarterly sales.</li>
	<li>10x Genomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) fell 21% to close at $144.45 following Q1 results.</li>
	<li>Nemaura Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) dipped 20.6% to close at $8.78 possibly on profit-taking after the stock rallied roughly 120% on Wednesday.</li>
	<li>Freeline Therapeutics Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRLN#NASDAQ">FRLN</a>) dropped 20.4% to close at $8.85. Guggenheim analyst Debjit Chattopadhyay initiated coverage on Freeline Therapeutics with a Buy rating and announced a price target of $17.</li>
	<li>U.S. Concrete, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCR#NASDAQ">USCR</a>) fell 18.3% to close at $54.61 after the company reported worse-than-expected Q1 results.</li>
	<li>Intrepid Potash, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) dropped 18% to settle at $26.90. The company recently released Q1 results.</li>
	<li>Home Point Capital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HMPT#NASDAQ">HMPT</a>) fell 17.7% to close at $7.72 following downbeat quarterly earnings.</li>
	<li>Aviat Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) dipped 16.7% to close at $28.35 after the company reported Q3 earnings results.</li>
	<li>Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) fell 16.6% to close at $19.01 after the company reported worse-than-expected Q1 earnings.</li>
	<li>Veru Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERU#NASDAQ">VERU</a>) dropped 16.3% to settle at $7.36. Veru recently announced that the Phase 2 results evaluating enobosarm for breast cancer include further efficacy data and an analysis of patients who have failed estrogen blocking agents and CDK 4/6 inhibitors.</li>
	<li>Agrify Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGFY#NASDAQ">AGFY</a>) fell 16.3% to close at $7.68.</li>
	<li>Laredo Petroleum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPI#NYSE">LPI</a>) dropped 16.2% to settle at $36.37 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>Amyris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRS#NASDAQ">AMRS</a>) fell 16.2% to settle at $11.41 following Q1 results.</li>
	<li>Grand Canyon Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) fell 16% to close at $89.77 after the company issued weak sales outlook.</li>
	<li>Immunic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMUX#NASDAQ">IMUX</a>) dipped 16% to close at $11.88 following Q1 results.</li>
	<li>Universal Security Instruments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUU#NYSE">UUU</a>) fell 15.8% to settle at $5.44.</li>
	<li>Redfin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) fell 15.7% to close at $52.43 following Q1 loss.</li>
	<li>Danimer Scientific, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNMR#NYSE">DNMR</a>) dipped 15.3% to settle at $17.66.</li>
	<li>Blue Apron Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APRN#NYSE">APRN</a>) dropped 15.2% to settle at $5.01 after the company reported Q1 results and issued weak sales forecast for the second quarter.</li>
	<li>Galmed Pharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLMD#NASDAQ">GLMD</a>) fell 14.9% to close at $2.65.</li>
	<li>Regis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGS#NYSE">RGS</a>) fell 14.7% to close at $10.27 after reporting downbeat Q3 results.</li>
	<li>Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) shares fell 14.6% to close at $157.68 after the company reported Q1 earnings results.</li>
	<li>Lee Enterprises, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEE#NASDAQ">LEE</a>) dipped 13.9% to close at $31.10 after reporting Q2 results.</li>
	<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCGN#NASDAQ">OCGN</a>) fell 12.2% to close at $9.58. Ocugen is expected to report Q1 earnings on Friday, May 7.</li>
	<li>Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) fell 11.6% to close at $84.15 after the company reported a Q1 loss.</li>
	<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) dropped 11.6% to settle at $15.23 after the company reported worse-than-expected Q1 results.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) shares fell 11.1% to settle at $4.50. Precipio recently launched its COVID-19 rapid antibody test on the Amazon.com Inc platform.</li>
	<li>Walker &amp; Dunlop, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WD#NYSE">WD</a>) dipped 11% to close at $100.73 following downbeat quarterly results.</li>
	<li>Synthetic Biologics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYN#NYSE">SYN</a>) declined 9.1% to close at $0.4598 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) fell 8.9% to close at $46.65 after the company reported Q1 earnings results.</li>
	<li>Cardinal Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) fell 7.1% to settle at $56.54 after the company reported worse-than-expected Q3 results.</li>
	<li>Allegiant Travel Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGT#NASDAQ">ALGT</a>) dropped 5.6% to close at $221.00 after the company priced its 1.35 million share common stock offering at $219 per share.</li>
</ul>

72 Biggest Movers From Yesterday

<h3>Gainers</h3>

<ul>
	<li>InnSuites Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHT#NYSE">IHT</a>) shares jumped 82.6% to settle at $6.39 on Monday.</li>
	<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares surged 53.5% to close at $3.27 on Monday on above-average news.</li>
	<li>Tecnoglass Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGLS#NASDAQ">TGLS</a>) jumped 31% to close at $16.03 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target of $10 to $15per share.</li>
	<li>Obalon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLN#NASDAQ">OBLN</a>) rose 30.5% to settle at $2.87.</li>
	<li>Cue Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) jumped 27.7% to close at $14.38 as the company reported confirmed partial response in ongoing Phase 1 monotherapy study of CUE-101 in late stage second line and beyond patients with HPV+ recurrent/metastatic head and neck cancer.</li>
	<li>Soliton, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOLY#NASDAQ">SOLY</a>) jumped 24.5% to close at $22.41 following $22.60 per share buyout from AbbVie Inc. AbbVie&rsquo;s Allergan Aesthetics unit will pay $550 million in cash to scoop up Soliton and Resonic, its sound-wave device that improves the appearance of cellulite.</li>
	<li>Alfi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALF#NASDAQ">ALF</a>) shares surged 23.5% to close at $4.57. The company recently appointed Ron Spears as Chief Revenue Officer.</li>
	<li>Datasea Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTSS#NASDAQ">DTSS</a>) rose 23.5% to settle at $3.31 after the company entered into distribution partnership with Jiade Boya Culture Co.</li>
	<li>Annovis Bio, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) gained 21.9% to close at $28.61.</li>
	<li>Exterran Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXTN#NYSE">EXTN</a>) gained 21.8% to close at $4.58. The company, last week, reported a Q1 loss.</li>
	<li>uCloudlink Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) surged 21.4% to settle at $12.99.</li>
	<li>Live Ventures Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVE#NASDAQ">LIVE</a>) jumped 20% to close at $45.00. The company, last week, reported preliminary record quarterly revenue for fiscal Q2.</li>
	<li>SilverBow Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBOW#NYSE">SBOW</a>) gained 20% to settle at $13.38.</li>
	<li>Select Interior Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIC#NASDAQ">SIC</a>) rose 19.2% to close at $10.64 after the company announced it entered into a definitive agreement to sell its Residential Design Services segment to Interior Logic Group for $215 million.</li>
	<li>Cellect Biotechnology Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOP#NASDAQ">APOP</a>) gained 18.8% to settle at $2.97.</li>
	<li>Intec Pharma Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTEC#NASDAQ">NTEC</a>) jumped 17.2% to close at $4.16.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) surged 15.6% to close at $4.44 after the company announced it launched a new, four-hour Acute Myeloid Leukemia HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) rose 15.4% to settle at $5.91.</li>
	<li>Troika Media Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRKA#NASDAQ">TRKA</a>) jumped 15.2% to close at $2.50.</li>
	<li>Huttig Building Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBP#NASDAQ">HBP</a>) rose 14.4% to settle at $6.20. The company, last week, released Q1 results.</li>
	<li>Alpha Metallurgical Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMR#NYSE">AMR</a>) surged 13.6% to close at $15.17 after the company reported better-than-expected Q1 EPS and sales results.</li>
	<li>TimkenSteel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMST#NYSE">TMST</a>) gained 13.1% to close at $14.75. Keybanc maintained TimkenSteel with an Overweight and raised the price target from $12 to $16.</li>
	<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) jumped 11.3% to settle at $293.45.</li>
	<li>Party City Holdco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRTY#NYSE">PRTY</a>) rose 11.1% to settle at $8.84 after the company reported better-than-expected Q1 results. The company issued strong Q2 sales guidance.</li>
	<li>BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) gained 10.2% to settle at $202.35 after the company announced plans to build headquarters for SE Asia, its first mRNA manufacturing facility in Singapore.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares gained 9.4% to close at $8.70 after dropping 22% on Friday.</li>
	<li>Armstrong Flooring, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFI#NYSE">AFI</a>) surged 8.4% to close at $6.19.</li>
	<li>Tenneco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEN#NYSE">TEN</a>) jumped 8% to close at $13.83. The company, last week, reported upbeat quarterly results.</li>
	<li>Heron Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) gained 5.6% to close at $17.56 after reporting a loss for the first quarter.</li>
</ul>

&nbsp;

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Rekor Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) shares fell 27.5% to close at $13.71 on Monday.</li>
	<li>The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) shares tumbled 26% to close at $489.60 on Monday after the company reported it is facing a period of higher uncertainty in its business outlook. The company&rsquo;s board also declared a ten-for-one split in the form of a stock dividend.</li>
	<li>Village Farms International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) fell 24.7% to close at $8.37 after the company swung to a loss in the first quarter.</li>
	<li>Magnite, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) fell 20.3% to close at $28.56.</li>
	<li>Insmed Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) fell 20.2% to settle at $25.99 after the company reported a proposed concurrent public offerings of $250 million of common stock and $500 million convertible senior notes due 2028. Morgan Stanley maintained Insmed with an Overweight and lowered the price target from $58 to $56.</li>
	<li>Soligenix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) fell 19.5% to close at $1.03.</li>
	<li>Dynavax Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVAX#NASDAQ">DVAX</a>) fell 19.5% to close at $7.90. Dynavax Technologies, last week, reported better-than-expected Q1 results.</li>
	<li>STAAR Surgical Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) fell 19.1% to settle at $111.51. The company, last week, reported Q1 results.</li>
	<li>CEVA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEVA#NASDAQ">CEVA</a>) dipped 18.7% to settle at $42.40 after reporting downbeat quarterly earnings.</li>
	<li>Applied UV, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVI#NASDAQ">AUVI</a>) fell 18.5% to close at $8.61.</li>
	<li>American Shared Hospital Services. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) fell 17.9% to settle at $2.80 after dipping around 18% on Friday.</li>
	<li>Twist Bioscience Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) dipped 17.5% to close at $96.33.</li>
	<li>Alset EHome International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEI#NASDAQ">AEI</a>) dropped 17.4% to settle at $6.34. Alset EHome International priced $32.0 million underwritten public offering of units.</li>
	<li>Onion Global Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OG#NYSE">OG</a>) fell 17.3% to close at $5.79. Onion Global priced its IPO at $7.25 per ADS on Friday.</li>
	<li>Revolve Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) fell 17.2% to close at $48.16.</li>
	<li>PubMatic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>) dipped 17.1% to close at $36.99.</li>
	<li>Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) fell 16.9% to settle at $23.04.</li>
	<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) dropped 16.8% to close at $12.63.</li>
	<li>HyreCar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYRE#NASDAQ">HYRE</a>) fell 16.5% to close at $10.84.</li>
	<li>Quanterix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTRX#NASDAQ">QTRX</a>) dipped 16.3% to settle at $46.96. The company, last week, reported Q1 results.</li>
	<li>Cambium Networks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) fell 16.2% to close at $49.09. The company, last week, reported upbeat quarterly results.</li>
	<li>Future FinTech Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) dipped 16.2% to settle at $2.90.</li>
	<li>CleanSpark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) fell 15.9% to close at $16.23. CleanSpark, last week, released Q2 results.</li>
	<li>Zymergen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZY#NASDAQ">ZY</a>) fell 15.8% to settle at $36.03.</li>
	<li>FutureFuel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) dropped 15.3% to settle at $11.22.</li>
	<li>Avalon Holdings Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWX#NYSE">AWX</a>) fell 14.6% to settle at $3.85 after gaining around 9% on Friday.</li>
	<li>So-Young International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) fell 14.4% to close at $7.53. The company, last week, reported a $70 million buyback plan.</li>
	<li>SciPlay Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPL#NASDAQ">SCPL</a>) shares fell 13.3% to close at $15.75 following downbeat quarterly earnings.</li>
	<li>Orgenesis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) fell 13.3% to close at $4.91. Orgenesis shares climbed over 24% on Friday after the company swung to a Q1 profit.</li>
	<li>Kodiak Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) fell 13% to close at $88.41.</li>
	<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) dipped 12.6% to close at $3.25. BioLineRx, last week, announced positive top-line results from GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, combined with granulocyte colony-stimulating factor (G-CSF), for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.</li>
	<li>Waterdrop Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) fell 12.4% to close at $8.50. Waterdrop shares fell 19% on Friday after the company priced its IPO at $12 per ADS.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) dipped 11.1% to close at $9.67.</li>
	<li>Dunxin Financial Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXF#NYSE">DXF</a>) fell 10.9% to close at $2.13.</li>
	<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) fell 7.8% to close at $17.15 after jumping 24% on Friday.</li>
</ul>

64 Biggest Movers From Yesterday

&nbsp;

<h3>Companies Reporting Before The Bell</h3>

&bull; Hycroft Mining Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYMC#NASDAQ">HYMC</a>) is estimated to report earnings for its first quarter.

&bull; U.S. Well Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USWS#NASDAQ">USWS</a>) is projected to report earnings for its first quarter.

&bull; Palatin Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) is estimated to report earnings for its third quarter.

&bull; RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is likely to report quarterly loss at $1.16 per share on revenue of $86.80 million.

&bull; Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) is projected to report quarterly loss at $0.02 per share on revenue of $2.46 million.

&bull; Paratek Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTK#NASDAQ">PRTK</a>) is likely to report quarterly loss at $0.38 per share on revenue of $28.72 million.

&bull; Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) is likely to report quarterly loss at $0.26 per share on revenue of $4.83 million.

&bull; Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) is likely to report quarterly earnings at $0.13 per share on revenue of $173.31 million.

&bull; Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) is likely to report quarterly loss at $0.02 per share on revenue of $7.40 million.

&bull; iBio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#AMEX">IBIO</a>) is expected to report earnings for its third quarter.

&bull; F-star Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTX#NASDAQ">FSTX</a>) is projected to report quarterly loss at $1.16 per share on revenue of $1.20 million.

&bull; Cerevel Therapeutics Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERE#NASDAQ">CERE</a>) is projected to report earnings for its first quarter.

&bull; AppHarvest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPH#NASDAQ">APPH</a>) is projected to report earnings for its first quarter.

&bull; Orbital Energy Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OEG#NASDAQ">OEG</a>) is expected to report quarterly loss at $0.15 per share on revenue of $15.51 million.

&bull; Ebix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBIX#NASDAQ">EBIX</a>) is expected to report quarterly earnings at $0.86 per share on revenue of $203.90 million.

&bull; Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) is likely to report quarterly loss at $0.47 per share on revenue of $2.09 million.

&bull; Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) is projected to report earnings for its first quarter.

&bull; Lion Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEV#NYSE">LEV</a>) is projected to report earnings for its first quarter.

&bull; Marinus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) is estimated to report quarterly loss at $0.45 per share on revenue of $2.57 million.

&bull; PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) is likely to report earnings for its first quarter.

&bull; Spark Networks (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LOV#AMEX">LOV</a>) is estimated to report quarterly loss at $0.45 per share on revenue of $56.15 million.

&bull; Akumin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKU#NASDAQ">AKU</a>) is estimated to report earnings for its first quarter.

&bull; Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $1.21 million.

&bull; Ryanair Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>) is likely to report quarterly loss at $1.78 per share on revenue of $193.52 million.

&bull; Niu Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $79.68 million.

&bull; Pieris Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIRS#NASDAQ">PIRS</a>) is expected to report quarterly loss at $0.17 per share on revenue of $6.47 million.

&bull; FreightCar America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIL#NASDAQ">RAIL</a>) is likely to report quarterly loss at $0.26 per share on revenue of $38.20 million.

&bull; China Online Education Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COE#NYSE">COE</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $93.15 million.

&bull; Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $3.75 million.

&bull; Hostess Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWNK#NASDAQ">TWNK</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $257.57 million.

&bull; Clover Health Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) is likely to report earnings for its first quarter.

&bull; Live Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVE#NASDAQ">LIVE</a>) is estimated to report earnings for its second quarter.

&bull; Titan Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDI#NASDAQ">TMDI</a>) is likely to report earnings for its first quarter.

&bull; Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is expected to report earnings for its first quarter.

&nbsp;

<h3>Companies Reporting After The Bell</h3>

&bull; Super League Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGG#NASDAQ">SLGG</a>) is expected to report earnings for its first quarter.

&bull; Arcimoto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUV#NASDAQ">FUV</a>) is expected to report quarterly loss at $0.12 per share on revenue of $1.39 million.

&bull; Adamis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $3.47 million.

&bull; Desktop Metal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DM#NYSE">DM</a>) is projected to report quarterly loss at $0.12 per share on revenue of $9.42 million.

&bull; GSE Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVP#NASDAQ">GVP</a>) is likely to report earnings for its first quarter.

&bull; Canoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) is estimated to report quarterly loss at $0.23 per share on revenue of $3.00 million.

&bull; AcelRx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRX#NASDAQ">ACRX</a>) is projected to report quarterly loss at $0.08 per share on revenue of $1.06 million.

&bull; SG Blocks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) is projected to report earnings for its first quarter.

&bull; Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) is estimated to report earnings for its second quarter.

&bull; Applied Genetic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGTC#NASDAQ">AGTC</a>) is projected to report earnings for its third quarter.

&bull; Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) is estimated to report quarterly loss at $0.31 per share on revenue of $14.06 million.

&bull; Ferroglobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSM#NASDAQ">GSM</a>) is expected to report earnings for its first quarter.

&bull; Clever Leaves Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVR#NASDAQ">CLVR</a>) is estimated to report earnings for its first quarter.

&bull; Metromile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MILE#NASDAQ">MILE</a>) is projected to report earnings for its first quarter.

&bull; Simon Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $59.36 million.

&bull; INVO Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) is projected to report earnings for its first quarter.

&bull; HighPeak Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPK#NASDAQ">HPK</a>) is projected to report earnings for its first quarter.

&bull; TOMI Environmental Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) is estimated to report earnings for its first quarter.

&bull; BM Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMTX#AMEX">BMTX</a>) is likely to report earnings for its first quarter.

&bull; Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) is expected to report quarterly loss at $0.19 per share on revenue of $250.91 million.

&bull; Leaf Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEAF#NYSE">LEAF</a>) is likely to report earnings for its first quarter.

&bull; XL Fleet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XL#NYSE">XL</a>) is expected to report quarterly loss at $0.03 per share on revenue of $970.00 thousand.

&bull; Danimer Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNMR#NYSE">DNMR</a>) is likely to report quarterly loss at $0.06 per share on revenue of $12.00 million.

&bull; Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) is estimated to report quarterly loss at $1.29 per share on revenue of $1.72 million.

&bull; Telos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) is expected to report quarterly loss at $0.04 per share on revenue of $49.99 million.

&bull; Porch Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) is estimated to report quarterly loss at $0.32 per share on revenue of $23.06 million.

&bull; XpresSpa Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XSPA#NASDAQ">XSPA</a>) is expected to report quarterly loss at $0.05 per share on revenue of $2.37 million.

&bull; Remark Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARK#NASDAQ">MARK</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $5.12 million.

&bull; Cue Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) is estimated to report quarterly loss at $0.38 per share on revenue of $590.00 thousand.

&bull; Reed&#39;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REED#NASDAQ">REED</a>) is projected to report quarterly loss at $0.03 per share on revenue of $10.90 million.

&bull; PAVmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVM#NASDAQ">PAVM</a>) is expected to report quarterly loss at $0.12 per share on revenue of $30.00 thousand.

&bull; GAN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAN#NASDAQ">GAN</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $24.81 million.

&bull; Quest Resource Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) is projected to report earnings for its first quarter.

&bull; Onconova Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONTX#NASDAQ">ONTX</a>) is expected to report quarterly loss at $0.03 per share on revenue of $60.00 thousand.

&bull; Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $21.30 million.

&bull; ENDRA Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) is expected to report earnings for its first quarter.

&bull; Arcadia Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKDA#NASDAQ">RKDA</a>) is expected to report quarterly loss at $0.30 per share on revenue of $850.00 thousand.

&bull; VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) is expected to report quarterly loss at $0.01 per share on revenue of $4.30 million.

&bull; OncoCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCX#NASDAQ">OCX</a>) is expected to report quarterly loss at $0.10 per share on revenue of $830.00 thousand.

&bull; Tencent Music Enter Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $1.20 billion.

&bull; CohBar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWBR#NASDAQ">CWBR</a>) is likely to report earnings for its first quarter.

&bull; DarioHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIO#NASDAQ">DRIO</a>) is likely to report quarterly loss at $1.04 per share on revenue of $3.96 million.

&bull; Verra Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRRM#NASDAQ">VRRM</a>) is estimated to report earnings for its first quarter.

&bull; Rockwell Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) is likely to report quarterly loss at $0.09 per share on revenue of $17.38 million.

&bull; Park City Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCYG#NASDAQ">PCYG</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $5.20 million.

&bull; Ideanomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) is likely to report quarterly loss at $0.18 per share on revenue of $11.10 million.

&bull; Consolidated Water Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $18.45 million.

&bull; Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $2.12 million.

&bull; Fisker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSR#NYSE">FSR</a>) is estimated to report earnings for its first quarter.

&bull; Atlas Technical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCX#NASDAQ">ATCX</a>) is likely to report quarterly loss at $0.35 per share on revenue of $118.03 million.

&bull; Luna Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNA#NASDAQ">LUNA</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $26.91 million.

&bull; ExOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XONE#NASDAQ">XONE</a>) is likely to report quarterly loss at $0.21 per share on revenue of $14.31 million.

&bull; CYREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRN#NASDAQ">CYRN</a>) is projected to report quarterly loss at $0.05 per share on revenue of $9.17 million.

&bull; SRAX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAX#NASDAQ">SRAX</a>) is projected to report quarterly loss at $0.10 per share on revenue of $5.68 million.

&bull; HireQuest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQI#NASDAQ">HQI</a>) is projected to report earnings for its first quarter.

&bull; Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) is likely to report earnings for its first quarter.

Earnings Scheduled For May 17, 2021

Early Tuesday morning, Hindenburg Research issued a short report on the sports betting company DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>).

What Happened: In a <a href="https://hindenburgresearch.com/draftkings/">report </a>called &ldquo;A $21 billion SPAC betting it can hide its black market operations,&rdquo; Hindenburg Research targets DraftKings&nbsp;and its fully owned SBTech unit.

The SPAC deal that brought DraftKings public was a three-way merger between the SPAC, DraftKings&nbsp;and Bulgaria-based gaming technology company SBTech. Hindenburg accuses SBTech of being a red flag unit hidden within the DraftKings business.

&ldquo;Unbeknownst to investors, DraftKings&rsquo; merger with SBTech also brings exposure to extensive dealings in black-market gaming, money laundering and organized crime,&rdquo; the report says.

Hindenburg spoke to former employees and reviewed SEC filings to find that SBTech, which will soon power DraftKings&rsquo; back-end infrastructure, has a record of operations in the black market.

According to Hindenburg, SBTech attempted to hide some of the illegal operations prior to the merger by spinning off a unit into a newly formed company called BTi/CoreTech.

At the time of the SPAC merger, SBTech represented 25% of the company&rsquo;s revenue and was the only positive contributor to positive operating income.

Hindenburg also questions the $1.4 billion in insider sales since the company going public with the founder of SBTech the biggest seller with transactions of around $568 million.

Related Link:<a href="https://www.benzinga.com/news/earnings/21/05/21012840/draftkings-q1-revenue-up-175-paying-users-rise-114"> DraftKings Q1 Revenue Up 175%, Paying Users Rise 114%</a>

Why It&rsquo;s Important: Since completing its SPAC merger, DraftKings has been one of the most successful companies to go public this route with shares up almost 400%.

Unlike other short reports that Hindenburg has put out, the accusations don&rsquo;t question the financials of DraftKings but rather the operations that are used for the money.

Also not lost on Hindenburg is the mention in the report that DraftKings has major partnerships with the NFL, NBA, Nascar, PGA and UFC.

Readers should also note that Hindenburg Research is holding a short position in shares of DraftKings. The firm has <a href="https://hindenburgresearch.com/">targeted </a>several companies that completed SPAC mergers in the past including Lordstown Motors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIDE#NASDAQ">RIDE</a>), Clover Health Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>), Nikola Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) and PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>).

Benzinga did not receive a response&nbsp;from DraftKings at the time of writing.

DKNG Price Action: Shares of DraftKings are down 6.7% to $47.18&nbsp;at publication time.

Sports

DraftKings Falls On Hindenburg Short Report, Calls Out Sports Betting Co. For Skirting Law & Hiding 'Black Market Operations'

Global industrial software and technology leader Emerson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) announced today the signing of a multi-year agreement with PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) to provide advanced digital technologies and automation for a network of global facilities, enabling large-scale recycling of a common &ndash; but rarely recycled &ndash; plastic.

Emerson&#39;s Plantweb&trade; digital ecosystem was chosen for the breadth of digital solutions, including intelligent sensors and control valves, advanced operations software and systems, cloud data management and analytics.

&quot;Unlike traditional manufacturing facilities coping with transforming legacy platforms to digital, PureCycle&#39;s progressive approach will enable all future facilities to be born digital,&quot; said Dustin Olson, chief manufacturing officer of PureCycle Technologies. &quot;With Emerson&#39;s help, each PureCycle facility is expected to start up with the most advanced digital automation technologies available, allowing for faster project completion, fully integrated systems and world-class operating performance.&quot;

Polypropylene, identified as resin recycling code #5, is one of the world&#39;s most frequently produced, versatile and widely used plastics in the world. Despite more than 170 billion tons being produced each year, less than&nbsp;1%&nbsp;is reclaimed annually for recycling and reuse. Polypropylene is commonly used in production of food and cosmetics packaging, toys, automobile parts and more.

&quot;PureCycle&#39;s first-of-its-kind technology purifies waste plastic to remove color, odor and other contaminants to create a near-virgin Ultra-Pure Recycled Polypropylene suitable for nearly any application,&quot; Olson said. &quot;This provides a pathway to reverse low rates of global polypropylene recycling and opens new opportunities for the plastics supply into all polypropylene applications.&quot;

&quot;Sustainability is driving incredible innovation across the industry,&quot; said Mike Train, chief sustainability officer of Emerson. &quot;New policies and long-range goals for decarbonization give us vision and direction that are important to the industry and to society. Emerson&#39;s digital automation software and technologies are helping companies like PureCycle make practical and measurable progress toward these goals today.&quot;

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-07-29
REV		(EXPECTED)2021-07-29

Q1 2021		Est.		Actual		Surprise
EPS				-0.590
REV				0

Recent Quotes

Earnings

Analyst Ratings

Related Companies

PureCycle Technologies Frequently Asked Questions

How do I buy PureCycle Technologies (PCT) stock?

Who are PureCycle Technologies's (PCT) competitors?

What is the target price for PureCycle Technologies (PCT) stock?

Current Stock Price for PureCycle Technologies (PCT)?

Does PureCycle Technologies (PCT) pay a dividend?

When is PureCycle Technologies (NASDAQ:PCT) reporting earnings?

Is PureCycle Technologies (PCT) going to split?

What sector and industry does PureCycle Technologies (PCT) operate in?